eli lilly glp 1 Lilly's oral GLP-1 pill may help people with Type 2 diabetes lose 'significant' weight, study finds The FDA has approved a
Description
Although Ozempic and Wegovy both contain the active ingredient Semaglutide, they are intended for different purposes and so have different dosages to reflect this
The developmen...
Two major ongoing trials are likely to change that, with potentially big implications for clinical practice.

Weight loss drugs continue to play out in the global market, with forecasts estimated at a value of US$200 billion by 2030.Leading the rise are oral GLP-1 drugs, with new obesity pills projected to push the GLP-1 market into its next chapter in 2026

Call to schedule a consult, and let's discuss your options